Exact Sciences
EXAS
#1149
Rank
โ‚น1.755 T
Marketcap
โ‚น9,250
Share price
0.24%
Change (1 day)
79.55%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): -โ‚น456.52

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -โ‚น483.68. In 2024 the company made an earnings per share (EPS) of -โ‚น506.41.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น456.52-9.85%
2024-โ‚น506.41
2022-โ‚น321.852.31%
2021-โ‚น314.57-38.54%
2020-โ‚น511.86692.96%
2019-โ‚น64.55-50.69%
2018-โ‚น130.9244%
2017-โ‚น90.92-39.39%
2016-โ‚น150.01-2.94%
2015-โ‚น154.5637.1%
2014-โ‚น112.7479.71%
2013-โ‚น62.73-21.59%
2012-โ‚น80.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Myriad Genetics
MYGN
-โ‚น393.67-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
โ‚น30.91-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
โ‚น35.46-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚น4,628 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น336.91-169.66%๐Ÿ‡ซ๐Ÿ‡ท France